155 related articles for article (PubMed ID: 11504083)
1. Non-invasive methods for absolute cerebral blood flow measurement using 99mTc-ECD: a study in healthy volunteers.
Van Laere K; Dumont F; Koole M; Dierckx R
Eur J Nucl Med; 2001 Jul; 28(7):862-72. PubMed ID: 11504083
[TBL] [Abstract][Full Text] [Related]
2. An alternative approach to estimation of the brain perfusion index for measurement of cerebral blood flow using technetium-99m compounds.
Murase K; Inoue T; Fujioka H; Ishimaru Y; Akamune A; Yamamoto Y; Mochizuki T; Ikezoe J
Eur J Nucl Med; 1999 Oct; 26(10):1333-9. PubMed ID: 10541833
[TBL] [Abstract][Full Text] [Related]
3. Interobserver variability of cerebral blood flow measurements obtained using spectral analysis and technetium-99m labeled compounds.
Takasawa M; Murase K; Oku N; Kawamata M; Nagayoshi M; Osaki Y; Imaizumi M; Yoshikawa T; Kitagawa K; Hori M; Hatazawa J
Ann Nucl Med; 2003 May; 17(3):255-9. PubMed ID: 12846551
[TBL] [Abstract][Full Text] [Related]
4. Variability study of a non-invasive approach to the absolute quantification of cerebral blood flow with 99Tcm-ECD using aortic activity as the arterial input estimate.
van Laere K; Van de Wiele C; Van Belle Y; Audenaert K; Dierckx R
Nucl Med Commun; 1999 Jan; 20(1):33-40. PubMed ID: 9949411
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults.
Van Laere K; Versijpt J; Audenaert K; Koole M; Goethals I; Achten E; Dierckx R
Eur J Nucl Med; 2001 Jul; 28(7):873-87. PubMed ID: 11504084
[TBL] [Abstract][Full Text] [Related]
6. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
Matsuda H; Yagishita A; Tsuji S; Hisada K
Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
[TBL] [Abstract][Full Text] [Related]
7. Spectral analysis of 99mTc-HMPAO for estimating cerebral blood flow: a comparison with H2(15)O PET.
Takasawa M; Murase K; Oku N; Kawamata M; Nagayoshi M; Imaizumi M; Yoshikawa T; Osaki Y; Kimura Y; Kajimoto K; Kitagawa K; Hori M; Hatazawa J
Ann Nucl Med; 2004 May; 18(3):243-9. PubMed ID: 15233286
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive quantification of cerebral blood flow using 99mTc-ECD and SPECT.
Odano I; Ohkubo M; Yokoi T
J Nucl Med; 1999 Oct; 40(10):1737-44. PubMed ID: 10520717
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of the brain perfusion index for measuring cerebral blood flow using technetium-99m compounds.
Murase K; Fujioka H; Inoue T; Ishimaru Y; Akamune A; Yamamoto Y; Mochizuki T; Ikezoe J
Eur J Nucl Med; 2001 Nov; 28(11):1640-6. PubMed ID: 11702105
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative measurements of cerebral blood flow using 99mTc-ECD radionuclide angiography, SPECT and one-point arterial sampling].
Isaka Y; Yoshikawa T; Narita M; Ashida K; Imaizumi M; Harada M
Kaku Igaku; 1996 Sep; 33(9):965-73. PubMed ID: 8921664
[TBL] [Abstract][Full Text] [Related]
11. Assessment of acetazolamide reactivity in cerebral blood flow using spectral analysis and technetium-99m hexamethylpropylene amine oxime.
Takasawa M; Murase K; Oku N; Yoshikawa T; Osaki Y; Imaizumi M; Matsuzawa H; Fujino K; Hashikawa K; Kitagawa K; Hori M; Matsumoto M
J Cereb Blood Flow Metab; 2002 Aug; 22(8):1004-9. PubMed ID: 12172386
[TBL] [Abstract][Full Text] [Related]
12. [Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L, L-ECD SPECT activated with acetazolamide].
Takeuchi R; Matsuda H; Sakahara H; Konishi J
Kaku Igaku; 1996 Nov; 33(11):1213-20. PubMed ID: 8986060
[TBL] [Abstract][Full Text] [Related]
13. Quantification of regional cerebral blood flow with continuous infusion of technetium-99m-ethyl cysteinate dimer.
Tsuchida T; Sadato N; Yonekura Y; Yamamoto K; Waki A; Sugimoto K; Yang JT; Ishizu K; Hayashi N; Ishii Y
J Nucl Med; 1997 Nov; 38(11):1699-702. PubMed ID: 9374336
[TBL] [Abstract][Full Text] [Related]
14. Automatic determination of brain perfusion index for measurement of cerebral blood flow using spectral analysis and 99mTc-HMPAO.
Takasawa M; Murase K; Oku N; Kawamata M; Imaizumi M; Yoshikawa T; Osaki Y; Paul AK; Kitagawa K; Matsumoto M; Hori M
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1443-6. PubMed ID: 12397462
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of cerebral blood flow with 99mTc-ECD SPECT and its potential clinical implications--analyzing the relationships between CBF and lifestyle disease].
Nemoto H; Nakai Y; Hatakeyama R; Shikano N; Jesmin S; Yamaguchi N
Kaku Igaku; 2012 Nov; 49(4):329-40. PubMed ID: 23402203
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-ECD brain SPECT in misery perfusion.
Shimosegawa E; Hatazawa J; Aizawa Y; Shouji Y; Hachiya T; Murakami M
J Nucl Med; 1997 May; 38(5):791-6. PubMed ID: 9170448
[TBL] [Abstract][Full Text] [Related]
17. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes in the cerebral distribution of 99mTc-ECD from infancy to adulthood.
Kuji I; Sumiya H; Niida Y; Takizawa N; Ikeda E; Tsuji S; Tonami N
J Nucl Med; 1999 Nov; 40(11):1818-23. PubMed ID: 10565776
[TBL] [Abstract][Full Text] [Related]
19. Extraction of arterial input function for measurement of brain perfusion index with 99mTc compounds using fuzzy clustering.
Murase K; Nagayoshi M; Uenishi Y; Kawamata M; Yamazaki Y; Takasawa M; Oku N; Hatazawa J
Nucl Med Commun; 2004 Mar; 25(3):299-303. PubMed ID: 15094450
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cerebral blood flow reserve in patients with cerebrovascular disease by SPECT using technetium-99m-L, L-ethyl cysteinate dimer.
Hori A; Harada M; Nishitani H; Uno M
J Med Invest; 2002 Aug; 49(3-4):134-41. PubMed ID: 12323002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
